deltatrials
Terminated OBSERVATIONAL NCT06207058

Evaluation of a Screen and Treat Protocol for Influenza

Evaluation of a Screen and Treat Protocol for Influenza in Socially Vulnerable Communities.

Sponsor: Tricore, Inc

Conditions Influenza
Interventions Baloxavir Marboxil
Updated 4 times since 2024 Last updated: May 7, 2025 Started: Jan 15, 2024 Primary completion: May 31, 2024 Completion: Jul 1, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Limited enrollment opportunities due to low rates of viral infections

A observational or N/A phase clinical study on Influenza, this trial is terminated or withdrawn. The trial is conducted by Tricore, Inc and has accumulated 4 data snapshots since 2024. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshotNot Yet Recruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jun 2025 · 9 months · monthly snapshotNot Yet Recruiting~Jun 2025 – present · 13 months · monthly snapshotTerminated

Change History

4 versions recorded
  1. Jun 2025 — Present [monthly]

    Terminated

    Status: Not Yet RecruitingTerminated

  2. Sep 2024 — Jun 2025 [monthly]

    Not Yet Recruiting

  3. Jul 2024 — Sep 2024 [monthly]

    Not Yet Recruiting

  4. Feb 2024 — Jul 2024 [monthly]

    Not Yet Recruiting

    First recorded

Jan 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Tricore, Inc
Data source: Tricore, Inc

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations